Potent aza-peptide derived inhibitors of HCV NS3 protease
摘要:
Chronic hepatitis C infection is the primary cause for cirrhosis of the liver and hepatocellular carcinoma leading to liver failure and transplantation. The etiological agent hepatitis C virus produces a single positive strand RNA that is processed further with the help of NS3 serine protease to produce mature virus. Inhibition of this protease can potentially be used to develop drugs for HCV infections. Boceprevir is a ketoamide derived novel inhibitor of HCV NS3 protease that has been progressed to clinical trials and proven to be efficacious in humans. Herein, we report our efforts in identifying an aza-peptide derivative as a potential second generation compound, that lacks electrophilic ketoamide group and are potent in enzyme and replicon assay. (C) 2009 Published by Elsevier Ltd.
Dutta, Anand S.; Giles, Michael, B.; Gormley, James J., Journal of the Chemical Society. Perkin transactions I, 1987, p. 111 - 120
作者:Dutta, Anand S.、Giles, Michael, B.、Gormley, James J.、Williams, Joseph C.、Kusner, Edward J.
DOI:——
日期:——
Catalytic hydrophosphorylation of alkyl- and acylhydrazones
作者:E. D. Matveeva、T. A. Podrugina、I. N. Kolesnikova、M. V. Prisyazhnoi、G. G. Karateev、N. S. Zefirov
DOI:10.1007/s11172-010-0095-2
日期:2010.2
N-Boc- and N-acylhydrazino phosphonates were obtained for the first time by hydrophosphorylation of the appropriate hydrazones of aliphatic and aromatic aldehydes and heterocyclic and aliphatic ketones in the presence of [tetra(tert-butyl)phthalocyanine]aluminum chloride as a catalyst.
Potent aza-peptide derived inhibitors of HCV NS3 protease
作者:Srikanth Venkatraman、Wanli Wu、Neng-Yang Shih、F. George Njoroge
DOI:10.1016/j.bmcl.2009.06.060
日期:2009.8
Chronic hepatitis C infection is the primary cause for cirrhosis of the liver and hepatocellular carcinoma leading to liver failure and transplantation. The etiological agent hepatitis C virus produces a single positive strand RNA that is processed further with the help of NS3 serine protease to produce mature virus. Inhibition of this protease can potentially be used to develop drugs for HCV infections. Boceprevir is a ketoamide derived novel inhibitor of HCV NS3 protease that has been progressed to clinical trials and proven to be efficacious in humans. Herein, we report our efforts in identifying an aza-peptide derivative as a potential second generation compound, that lacks electrophilic ketoamide group and are potent in enzyme and replicon assay. (C) 2009 Published by Elsevier Ltd.